ClinicalTrials.gg
RecruitingNCT07852936Updated Oct 1, 2026

Group-based Emotional Awareness and Expression Therapy to Support Recovery After Acquired Brain Injury: A Clinical Development and Evaluation Study

An interventional study of TAU + Group Therapy (EAET) and Treatment as Usual (TAU) in Aquired Brain Injury, Stroke and MTBI - Mild Traumatic Brain Injury, sponsored by Uppsala University. Recruiting at 1 site in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-01.

Sponsored by Uppsala University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Sep 2026; still recruiting 2 months later.
Updated Oct 1, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
110
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 158 studies in Stroke with a site in Sweden — 30 open to participants now, 42 under way, 5 of them phase 3. Stroke · Sweden.

Planned enrollment
70th of 123
110 · median 200
Started
2026
with 8 others
No phase
74 of 158
18 open now
Primary completion
2031-06
later than 41 of 41 live
Registered
158th of 158
by date

Among the 158 studies in Stroke with a site in Sweden, this one is the 70th largest by planned enrollment of the 123 interventional ones that give a count, is one of 9 that started in 2026, is one of 74 with no phase, reaches primary completion later than 41 of the 41 other live ones, and was the 158th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

30 of the 158 studies in Stroke with a site in Sweden are open now. Recruiting first, the newest first:

24 more — sign in →

All 30 open studies →

A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 158 studies in Stroke with a site in Sweden, or all of them as a file.
02

Study summary

Difficulties in understanding and managing emotions may hinder recovery, rehabilitation, and participation in everyday life after acquired brain injury (ABI). Yet interventions targeting emotional adjustment after ABI remain limited.

The aim of the study is to investigate whether emotion-focused group therapy, based on Emotional Awareness and Expression Therapy (EAET), can support recovery after ABI. The intervention helps participants identify, process, and express emotions and needs related to their illness and changed life circumstances. Effects on emotional functioning, quality of life, activity, and participation will be assessed over time, alongside interviews exploring participants' experiences.

Read the detailed description

Surviving an acquired brain injury (ABI) often means having to learn to live with changes in abilities, roles, and relationships. For some, this adaptation itself becomes a barrier to continued recovery. Difficulties in understanding and managing emotions such as grief, fear and anger may affect how a person relates to their altered functional capacity, engages in rehabilitation, and resumes everyday activities and roles. Despite this, rehabilitation after ABI is primarily focused on physical and cognitive consequences, while targeted treatment options addressing emotional adjustment remain limited.

The aim of the study is to investigate whether emotion-focused group therapy can improve this aspect of recovery after ABI. The intervention is based on Emotional Awareness and Expression Therapy (EAET) and helps participants identify, process, and express emotions and needs that have emerged in response to the illness and changes in their life circumstances. The effects of the treatment on emotional functioning, quality of life, activity, and participation will be assessed over time and complemented by interviews exploring participants' experiences of the treatment and of life after stroke.

03

Conditions studied

  • Aquired Brain Injury
  • Stroke
  • MTBI - Mild Traumatic Brain Injury
  • mTBI
  • Encephalitis
  • Meningitis
  • Hypoxia Ischemia, Cerebral

Keywords

  • EAET
  • Emotional Awareness and Expression Therapy
  • Psychotherapy
  • Psychodynamic Psychotherapy
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Person of working age, primarily 18-65 years.
  • Acquired brain injury.
  • At least three months since the time of injury.
  • Signs of significant psychological distress, such as mental health difficulties, vulnerability to mental health problems, or dysfunctional coping.
  • Sufficient cognitive functioning and proficiency in Swedish to participate in group-based talk therapy.

Exclusion criteria

Exclusion Criteria:

  • Current severe mental illness (e.g., psychosis or severe personality disorder).
  • Active substance use disorder.
  • Severe cognitive impairment that precludes participation in group-based talk therapy.
  • Other medical conditions that, based on clinical assessment, may make participation inappropriate.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
110 participants (estimated)

Study arms

  • Active comparator
    Arm 1

    Treatment as Usual

    Behavioral: Treatment as Usual (TAU)

  • Experimental
    Arm 2

    Treatment as Usual + Group Therapy (EAET)

    Behavioral: TAU + Group Therapy (EAET)

Interventions

  • BehavioralTAU + Group Therapy (EAET)

    Behavioral: Treatment as usual • Individually tailored multidisciplinary rehabilitation based on an assessment of each participant's rehabilitation needs. An individual rehabilitation plan is developed, and interventions are provided by relevant members of the rehabilitation team according to the participant's identified needs. Rehabilitation may include medical management, occupational therapy, physiotherapy, psychological treatment, and psychosocial support. Behavioral: Group-based Emotional and Expression Therapy (EAET) • 10-session manualized group-based Emotional Awareness and Expression Therapy (EAET) designed to help participants identify, process, and express emotions and needs. Weekly group sessions are complemented by structured homework assignments. A follow-up session is provided three months after completion of the intervention. The intervention is delivered by a clinical psychologist.

  • BehavioralTreatment as Usual (TAU)

    Individually tailored multidisciplinary rehabilitation based on an assessment of each participant's rehabilitation needs. An individual rehabilitation plan is developed, and interventions are provided by relevant members of the rehabilitation team according to the participant's identified needs. Rehabilitation may include medical management, occupational therapy, physiotherapy, psychological treatment, and psychosocial support.

06

What researchers measure

Primary outcomes

  1. Brief Mentalized Affectivity Scale (B-MAS)

    Evalutates three core components of emotion regulation: "Identifying emotions"; "Processing emotions", "Expressing emotions".

    Time frame: Baseline (pre-intervention), post-treatment (10 weeks after baseline), 3-month follow-up (approximately 22 weeks after baseline), 12-month follow-up (approximately 62 weeks after baseline).

Secondary outcomes

  1. Quality of Life after Brain Injury (QOLIBRI)

    QOLIBRI consists of 37 items in six scales. Health-related quality of life is assessed in the areas of "Cognition," "Self," "Daily Life and Autonomy," and "Social Relationships," and feeling bothered by "Emotions," and "Physical Problems."

    Time frame: Pre-intervention, after 10 weeks (following completion of the intervention), after 22 weeks, and after 62 weeks.

  2. Quality of Life after Brain Injury Overall Scale (QOLIBRI-OS)

    Six item scale that ask about health related quality of life in six dimensions: "Physical condition, "Cognition", "Emotions", "Ability to carry out daily activities", "Personal and social life" and "Current situation and future prospects"

    Time frame: Pre-intervention, after 10 weeks (following completion of the intervention), after 22 weeks, and after 62 weeks.

  3. Short Form 36 (SF-36)

    The SF-36 measures eight scales: physical functioning (PF), role physical (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role emotional (RE), and mental health (MH).

    Time frame: Pre-intervention, after 10 weeks (following completion of the intervention), after 22 weeks, and after 62 weeks.

  4. Rivermead Post-Concussion Symptoms Questionnaire (RPQ)

    Score of 0-64, with a higher score indicates worse symptoms.

    Time frame: Pre-intervention, after 10 weeks (following completion of the intervention), after 22 weeks, and after 62 weeks.

  5. Insomnia Severity Index (ISI)

    Score of 0-28, where higher scores indicate severity of insomnia.

    Time frame: Pre-intervention, after 10 weeks (following completion of the intervention), after 22 weeks, and after 62 weeks.

  6. Generalized Anxiety Disorder 7-Item Scale (GAD-7)

    Score of 0-15, where higher scores indicate severity of anxiety experienced.

    Time frame: Pre-intervention, after 10 weeks (following completion of the intervention), after 22 weeks, and after 62 weeks.

  7. Patient Health Questionnaire-9 (PHQ-9)

    Score of 0-27, where higher scores indicate severity of depression experienced.

    Time frame: Pre-intervention, after 10 weeks (following completion of the intervention), after 22 weeks, and after 62 weeks.

  8. Patient Health Questionnaire-15 (PHQ-15)

    Score of 0-30, where higher scores indicate severity and burden of common physical symptoms.

    Time frame: Pre-intervention, after 10 weeks (following completion of the intervention), after 22 weeks, and after 62 weeks.

  9. Fear Avoidance Behavior after Traumatic Brain Injury Questionnaire (FAB-TBI)

    Score of 0-48, where higher score indicates higher avoidance.

    Time frame: Pre-intervention, after 10 weeks (following completion of the intervention), after 22 weeks, and after 62 weeks.

  10. Behavioral Responses to Illness Questionnaire (BRIQ)

    Evalutates behavioral response to illness on a four factor subscale: "All-or-Nothing Behavior", "Limiting Behavior", "Emotional Support Seeking" and "Practical Support Seeking".

    Time frame: Pre-intervention, after 10 weeks (following completion of the intervention), after 22 weeks, and after 62 weeks.

  11. Alcohol Use Disorders Identification Test (AUDIT)

    Score of 0-40, where higher score indicates greater risk of problematic alcohol use.

    Time frame: Pre-intervention, after 10 weeks (following completion of the intervention), after 22 weeks, and after 62 weeks.

  12. Drug Use Disorders Identification Test (DUDIT)

    Score of 0-44, where higher score indicates greater risk of problematic drug use.

    Time frame: Pre-intervention, after 10 weeks (following completion of the intervention), after 22 weeks, and after 62 weeks.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2026 (actual). Primary completion is estimated for Jun 2031, 57 months after the start.

Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 57 months is above that.

Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 25, 2026
First posted
Oct 1, 2026
StartActual
Sep 15, 2026
Primary completionEst.
Jun 2031
CompletionEst.
Jun 2031
Last update
Oct 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 1, 2026
Show all 1 update
  1. Oct 1, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07852936
Lead sponsor
Uppsala University
Collaborators
Region Uppsala Public Health and Care
Responsible party
Sponsor
First posted
Oct 1, 2026
Start date
Sep 15, 2026
Primary completion
Jun 2031 (estimated)
Completion
Jun 2031 (estimated)
Last update
Oct 1, 2026

Study contacts

Jakob Nissen, Licensed Clinical Psychologist
Contact
jakob.nissen@akademiska.se
0046 18 611 24 85
Anna Nordström, M.D.
study chair · Uppsala University
Peter Nordström, Professor
study chair · Uppsala University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion